Akorn Inc (AKRX.O)
April 25 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:
FRANKFURT German healthcare group Fresenius SE & Co KGaA has stepped up its dealmaking, agreeing to buy U.S. generic drugmaker Akorn Inc for $4.75 billion (4.37 billion euros) and the biosimilars arm of Germany's Merck KGaA.
* Fresenius shares up almost 1 percent (Adds advisers, shares, background, CEO, analyst comments)
FRANKFURT, April 25 The DAX top-30 index looked set to open 0.3 percent higher on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0625 GMT.
* Akorn - deal with Fresenius Kabi provides under specified circumstances, co to be required to pay Fresenius Kabi AG termination fee of $129 million Source text: (http://bit.ly/2oEMWQV) Further company coverage:
FRANKFURT, April 24 Acquisitive German healthcare conglomerate Fresenius SE & Co KGaA revved up its deals pace by acquiring U.S. generic drugmaker Akorn Inc for $4.75 billion (4.37 billion euros), and in a separate deal, the biosimilars unit of German peer Merck KGaA .
German healthcare conglomerate Fresenius SE & Co KGaA is close to acquiring generic drugmaker Akorn Inc in an all-cash deal valuing the company at more than $4 billion, people familiar with the matter said on Monday.
Generic drugmaker Akorn Inc must pay $20.5 million in a lawsuit by a Georgia teacher who accused the company of failing to warn that one of its products would react adversely with another medication she was already taking, a state court jury has ruled.
FRANKFURT/BERLIN, April 10 The DAX top-30 index looked set to open 0.2 percent higher on Monday, according to premarket data from brokerage Lang & Schwarz at 0608 GMT.
German healthcare group Fresenius SE & Co KGaA said on Friday that it was in talks with the generic drugmaker Akorn Inc for a potential takeover.
|Novartis AG (NOVN.S)||CHF76.15||+0.45|
|Pfizer Limited (PFIZ.NS)||Rs1,741.85||-55.90|
|Hikma Pharmaceuticals Plc (HIK.L)||1,944.00||+39.00|
|Fresenius Kabi Oncology Ltd (FRES.M3)||--||--|
|Mylan NV (MYL.OQ)||$37.78||+0.93|
|Taro Pharmaceutical Industries Ltd. (TARO.N)||$115.50||+1.29|
|Valeant Pharmaceuticals Intl Inc (VRX.TO)||$12.72||+0.46|
|Johnson & Johnson (JNJ.N)||$123.97||+0.54|